Electroporation-mediated HGF gene transfer increases mesenchymal stem cell and decreases MMP24 levels in a bleomycin-induced lung injury model.

A. Gazdhar (Bern, Switzerland), K. Fytianos (Bern, Switzerland), S. Pantasis (Zurich, Switzerland), S. Mykoniati (Delemont, Switzerland), M. Bordoli (Zurich, Switzerland), F. Batty (St Gallen, Switzerland), K. Hostettler (Basel, Switzerland), T. Geiser (Bern, Switzerland)

Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Session: New mechanistic insights into pulmonary fibrosis
Session type: Thematic Poster
Number: 2416
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Gazdhar (Bern, Switzerland), K. Fytianos (Bern, Switzerland), S. Pantasis (Zurich, Switzerland), S. Mykoniati (Delemont, Switzerland), M. Bordoli (Zurich, Switzerland), F. Batty (St Gallen, Switzerland), K. Hostettler (Basel, Switzerland), T. Geiser (Bern, Switzerland). Electroporation-mediated HGF gene transfer increases mesenchymal stem cell and decreases MMP24 levels in a bleomycin-induced lung injury model.. 2416

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008

Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells
Source: Eur Respir J 2012; 39: 446-457
Year: 2012



Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury
Source: Eur Respir J, 59 (1) 2004216; 10.1183/13993003.04216-2020
Year: 2022



Decreased expression of FENDRR, a lung mesenchymal long non-coding RNA, regulates fibroblast phenotypes in IPF through NOX4.
Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases
Year: 2017



Mesenchymal stem cell based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysacharride in mice
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008

Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011

Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung
Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair
Year: 2012

Multipotent stromal cell-derived stanniocalcin-1 reduces reactive oxygen species and promotes survival of injured A549 lung cancer cells through upregulation of uncoupling-protein 2 and induction of the Warburg effect
Source: Annual Congress 2010 - New insights into reactive oxygen species
Year: 2010


Electroporation of Hepatocyte growth factor to the lung induces migration of bone marrow mesenchymal stem cells and reduces lung fibrosis
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018


Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma
Source: Eur Respir J 2011; 38: 679-687
Year: 2011



Krüppel-like factor 4 (Klf4) is a novel regulator of neonatal lung fibroblast homeostasis and reduced in hyperoxia-induced lung injury
Source: International Congress 2018 – Molecular and cellular determinants of the developing lung
Year: 2018

Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011

In vitro profibrotic effects of rapamycin on basal or TGF-β1 induced primary human lung fibroblast: ECM production and turnover, migration and differentiation
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012

Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

Mechanistic target of rapamycin enhances fibrosis in lung by promoting epithelial mesenchymal transition
Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2019



Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010


Impaired angiogenic supportive capacity and altered gene expression profile of CD146 mesenchymal stromal cells isolated from hyperoxia-injured neonatal rat lungs
Source: ERS Lung Science Conference 2018
Year: 2018

IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020